Press Releases April 23, 2026 08:00 AM

Aspen Aerogels, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call

Aspen Aerogels schedules Q1 2026 earnings release and conference call with leadership

By Jordan Park ASPN
Aspen Aerogels, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call
ASPN

Aspen Aerogels, Inc. announced its first quarter 2026 earnings release scheduled for May 7, 2026, including a conference call hosted by CEO Don Young and CFO Grant Thoele. The company will discuss financial results from the quarter ended March 31, 2026. Aspen Aerogels specializes in aerogel technology that supports sustainability, electrification, and clean energy solutions across various industries, including electric vehicles and energy infrastructure.

Key Points

  • Aspen Aerogels to release Q1 2026 financial results on May 7, 2026, before market open, with a conference call at 8:30 a.m. ET.
  • The company’s aerogel technology addresses key global trends such as resource efficiency, e-mobility, and clean energy, serving electric vehicle and energy infrastructure markets.
  • Aspen emphasizes its partnerships with industry leaders to expand aerogel applications into additional high-value markets.

NORTHBOROUGH, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the "Company") today announced that Don Young, President & Chief Executive Officer, and Grant Thoele, Chief Financial Officer & Treasurer, expect to discuss the Company's financial results for the first quarter ended March 31, 2026, during a conference call scheduled for Thursday, May 7, 2026, at 8:30 a.m. ET. The Company also expects to release its quarterly financial results before the market opens on Thursday, May 7, 2026.

Shareholders and other interested parties may participate in the conference call by dialing +1 (833) 461-5787 (domestic) or +1 (585) 542-9983 (international) and entering Meeting ID “717749648” a few minutes before 8:30 a.m. ET on Thursday, May 7, 2026. In addition, the conference call and an accompanying slide presentation will be available live as a listen-only webcast hosted on the Investors section of Aspen’s website, www.aerogel.com.

A replay of the webcast will be available on the Investors section of the Aspen website at www.aerogel.com, where it will remain available for approximately one year after the conference call.

About Aspen Aerogels, Inc.
Aspen is a technology leader in sustainability and electrification solutions. The Company's aerogel technology enables its customers and partners to achieve their own objectives around the global megatrends of resource efficiency, e-mobility and clean energy. Aspen's PyroThin® products enable solutions to thermal runaway challenges within the electric vehicle ("EV") market. The Company's Cryogel® and Pyrogel® products are valued by the world's largest energy infrastructure companies. Aspen's strategy is to partner with world-class industry leaders to leverage its Aerogel Technology Platform® into additional high-value markets. Aspen is headquartered in Northborough, Mass. For more information, please visit www.aerogel.com.

Investor Relations & Media Contacts:
Neal Baranosky                                        
[email protected]        
Phone: (508) 691-1111 x 8                                
                        
Georg Venturatos / Patrick Hall
Gateway Group
[email protected]
Phone: (949) 574-3860


Risks

  • Financial results for Q1 2026 are not yet disclosed, creating uncertainty about company performance and potential market reactions.
  • Dependence on partnerships and adoption by the EV and energy sectors may impact revenue stability due to sector-specific market dynamics.
  • Broader economic conditions affecting sustainability investments and energy infrastructure spending could influence Aspen's growth prospects and earnings.

More from Press Releases

Fiverr Announces First Quarter 2026 Results Apr 29, 2026 Nayax to Report 2026 Q1 Earnings on May 12, 2026 Apr 28, 2026 Xunlei Filed Its Annual Report on Form 20-F for Fiscal Year 2025 Apr 28, 2026 Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain Apr 28, 2026 Syntec Optics (Nasdaq: OPTX) Announces Pricing of $20 Million Underwritten Public Offering of Common Stock Apr 28, 2026